Development of a High Sensitivity ELISA for the Assay of Metallothionein

Author(s): Takeaki Nagamine, Katsuyuki Nakajima

Journal Name: Current Pharmaceutical Biotechnology

Volume 14 , Issue 4 , 2013

Become EABM
Become Reviewer


We have developed a competitive ELISA using a polyclonal antibody that showed specificity to both metallothionin (MT)-1 and MT-2 isoforms in human and animal specimens. The advantage of this ELISA depends on the characteristics of the polyclonal antibody. The NH2 terminal peptide of MT with acetylated methionine was shown to be the epitope of this antibody. The reactivity of this ELISA system with liver, kidney, and brain extracts worked very well for MT1,2 in wild type mice. Extracts of MT-3 knock-out mice also react well this ELISA, as expected, very low in MT 1,2 but in MT1/2 knock-out mice. Detection limits, the ranges of linearity, and reliability coefficients of MT quantification of the ELISA were suitable for determination of MT. From the preliminary study of normal reference ranges, we found that normal MT levels were between approximately 10-30 ng/ml in human serum. We expect in the future to detect cases with low (MT deficiency) and high serum MT concentrations in patients with various diseases, such as brain/liver disorders, and cancers, using this MT ELISA.

Keywords: Acetylated methionine residue, competitive enzyme-linked immunosorbent assay, epitope mapping, metallothionein, metallothionein-null mouse, metallothionein isoforms.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [427 - 431]
Pages: 5
DOI: 10.2174/1389201011314040007
Price: $65

Article Metrics

PDF: 7